Reactive oxygen: its sources and significance in Alzheimer disease
Over the past decade, oxidative stress has been established as the earliest cytological feature of Alzheimer disease and an attractive therapeutic target. The major challenges now are establishing the source of the reactive oxygen and what oxidative stress tells us about the etiology of Alzheimer disease. These are complex issues since a variety of enzymatic and nonenzymatic processes are involved in reactive oxygen formation and damage to macromolecules. In this review, we consider disease mechanisms that show the greatest promise for future research.
KeywordsAlzheimer Disease Down Syndrome Dystrophic Neurites Mitochondrial Abnormality Vulnerable Neuron
Unable to display preview. Download preview PDF.
- Small GW, Komo S, La Rue A, Saxena S, Phelps ME, Mazziotta JC, Saunders AM, Haines JL, Pericak-Vance MA, Roses AD (1996) Early detection of Alzheimer’s disease by combining apolipoprotein E and neuroimaging. AnnNY Acad Sci 802: 7078Google Scholar
- Smith MA, Perry G, Richey PL, Sayre LM, Anderson VE, Beal MF, Kowall N (1996) Oxidative damage in Alzheimer’s. Nature 382: 120–121 Smith MA, Harris PLR, Sayre LM, Beckman JS, Perry G (1997a) Widespread peroxynitrite-mediated damage in Alzheimer’s disease. J Neurosci 17: 2653–2657Google Scholar
- Takeda A, Smith MA, Avila J, Nunomura A, Siedlak SL, Zhu X, Perry G, Sayre LM (2000b) In Alzheimer’s disease, heme oxygenase is coincident with Alz50, an epitope of’t induced by 4-hydroxy-2-nonenal modification. J Neurochem 75: 1234-1241Google Scholar
- Wataya T, Nunomura A, Smith MA, Siedlak SL, Harris PLR, Shimoharna S, Szweda LI, Kaminski MA, Avila J, Price DL, Cleveland DW, Sayre LM, Perry G (2002) High molecular weight neurofilament proteins are physiological substrates of adduction by the lipid peroxidation product hydroxynonenal. J Bioi Chern 277: 4644–4648CrossRefGoogle Scholar
- Yan SD, Yan SF, Chen X, Fu J, Chen M, Kuppusamy P, Smith MA, Perry G, Godman GC, Nawroth P, Zweier JL, Stern D (1995) Non-enzymatically glycated tau in Alzheimer’s disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid B-peptide. Nat Med 1: 693–699PubMedCrossRefGoogle Scholar